Carlsmed Statistics

Total Valuation

Carlsmed has a market cap or net worth of $365.39 million. The enterprise value is $339.05 million.

Market Cap	365.39M
Enterprise Value	339.05M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Carlsmed has 26.52 million shares outstanding.

Current Share Class	26.52M
Shares Outstanding	26.52M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+7.58%
Owned by Insiders (%)	11.00%
Owned by Institutions (%)	n/a
Float	9.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.87
Forward PS	n/a
PB Ratio	11.38
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.48, with a Debt / Equity ratio of 0.53.

Current Ratio	6.48
Quick Ratio	6.16
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.77

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-49.55%
Revenue Per Employee	$362,562
Profits Per Employee	-$288,933
Employee Count	89
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.39
Average Volume (20 Days)	444,524

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Carlsmed had revenue of $32.27 million and -$25.72 million in losses. Loss per share was -$1.11.

Revenue	32.27M
Gross Profit	24.02M
Operating Income	-24.51M
Pretax Income	-25.72M
Net Income	-25.72M
EBITDA	-24.37M
EBIT	-24.51M
Loss Per Share	-$1.11

Full Income Statement

Balance Sheet

The company has $43.43 million in cash and $17.08 million in debt, giving a net cash position of $26.35 million or $0.99 per share.

Cash & Cash Equivalents	43.43M
Total Debt	17.08M
Net Cash	26.35M
Net Cash Per Share	$0.99
Equity (Book Value)	32.12M
Book Value Per Share	-3.19
Working Capital	45.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26.21 million and capital expenditures -$213,000, giving a free cash flow of -$26.42 million.

Operating Cash Flow	-26.21M
Capital Expenditures	-213,000
Free Cash Flow	-26.42M
FCF Per Share	-$1.00

Full Cash Flow Statement

Margins

Gross margin is 74.44%, with operating and profit margins of -75.96% and -76.05%.

Gross Margin	74.44%
Operating Margin	-75.96%
Pretax Margin	-76.05%
Profit Margin	-76.05%
EBITDA Margin	-75.51%
EBIT Margin	-75.96%
FCF Margin	n/a

Dividends & Yields

Carlsmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.04%
FCF Yield	-7.23%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Carlsmed has an Altman Z-Score of -1.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.75
Piotroski F-Score	n/a